FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123515677> ?p ?o ?g. }

• W2123515677 endingPage "S142" @default.
• W2123515677 startingPage "S142" @default.
• W2123515677 abstract "Patients with multiple myeloma (MM) incur significant degradation in quality of life because of progressive osteolytic vertebral fractures. No studies have investigated predictors of fracture progression, and limited data are available for predicting the development of future fractures.The purpose of this study was to identify independent predictors of vertebral fracture progression and the development of future vertebral fracture.This is a consecutive retrospective chart review at a single tertiary-care center.Patients with MM and pathologic vertebral fracture with radiographic follow-up between January 2007 and December 2013 were included. Radiographic measurements were recorded at presentation with fracture and first follow-up (FFU) after at least three months. Patients with a history of vertebral fracture not associated with MM were excluded.The primary outcome measure was the rate of vertebral body height loss. The development of future vertebral fracture was secondary.Anterior, middle, and posterior vertebral body heights were measured from midline sagittal T1-weighted magnetic resonance imaging (MRI). Future fracture-free survival was calculated using Kaplan-Meier analysis. Multivariable regression was used to identify independent predictors of the rate of vertebral height loss. Multivariable Cox proportional hazards modeling was used to identify predictors of developing future vertebral fracture.Thirty-three patients with 67 fractures were followed for a median of 10.8 months to FFU. Sixty-four percent of the patients were female and the median age was 66. The median additional vertebral height loss between presentation and FFU was 15%, whereas the median rate of vertebral height loss was 1.01%/month. More rapid vertebral height loss was predicted by dyslipidemia (β=0.36, p=.05), previous non-vertebral pathologic fracture related to MM (β=0.51, p=.01), and Durie-Salmon Stage III (β=0.66, p=.06). The median time to future fracture was 25.1 months; the 5-year future fracture-free survival rate was 34%. Osteopenia/osteoporosis (hazard ratio [HR]: 9.28, p<.01), serum light chains (HR: 1.37, p=.06), and serum calcium (HR: 1.62, p=.05) predicted the development of future vertebral fracture.We observed significant fracture progression over a short follow-up period. Several comorbidities and laboratory measures predicted more rapid vertebral height loss and the development of future fracture. Identifying risk factors for increased fracture burden may allow spine specialists to pursue earlier and appropriate intervention to optimize function and minimize morbidity." @default.
• W2123515677 created "2016-06-24" @default.
• W2123515677 creator A5059354440 @default.
• W2123515677 creator A5067537941 @default.
• W2123515677 creator A5075078684 @default.
• W2123515677 creator A5077409711 @default.
• W2123515677 creator A5091011625 @default.
• W2123515677 date "2012-05-01" @default.
• W2123515677 modified "2023-09-24" @default.
• W2123515677 title "Anemia and the risk of non-vertebral fractures: the CEOR study" @default.
• W2123515677 doi "https://doi.org/10.1016/j.bone.2012.02.439" @default.
• W2123515677 hasPublicationYear "2012" @default.
• W2123515677 type Work @default.
• W2123515677 sameAs 2123515677 @default.
• W2123515677 citedByCount "0" @default.
• W2123515677 crossrefType "journal-article" @default.
• W2123515677 hasAuthorship W2123515677A5059354440 @default.
• W2123515677 hasAuthorship W2123515677A5067537941 @default.
• W2123515677 hasAuthorship W2123515677A5075078684 @default.
• W2123515677 hasAuthorship W2123515677A5077409711 @default.
• W2123515677 hasAuthorship W2123515677A5091011625 @default.
• W2123515677 hasConcept C126322002 @default.
• W2123515677 hasConcept C126838900 @default.
• W2123515677 hasConcept C141071460 @default.
• W2123515677 hasConcept C143409427 @default.
• W2123515677 hasConcept C167135981 @default.
• W2123515677 hasConcept C178910020 @default.
• W2123515677 hasConcept C2776541429 @default.
• W2123515677 hasConcept C36454342 @default.
• W2123515677 hasConcept C50382708 @default.
• W2123515677 hasConcept C71924100 @default.
• W2123515677 hasConceptScore W2123515677C126322002 @default.
• W2123515677 hasConceptScore W2123515677C126838900 @default.
• W2123515677 hasConceptScore W2123515677C141071460 @default.
• W2123515677 hasConceptScore W2123515677C143409427 @default.
• W2123515677 hasConceptScore W2123515677C167135981 @default.
• W2123515677 hasConceptScore W2123515677C178910020 @default.
• W2123515677 hasConceptScore W2123515677C2776541429 @default.
• W2123515677 hasConceptScore W2123515677C36454342 @default.
• W2123515677 hasConceptScore W2123515677C50382708 @default.
• W2123515677 hasConceptScore W2123515677C71924100 @default.
• W2123515677 hasLocation W21235156771 @default.
• W2123515677 hasOpenAccess W2123515677 @default.
• W2123515677 hasPrimaryLocation W21235156771 @default.
• W2123515677 hasRelatedWork W1849369517 @default.
• W2123515677 hasRelatedWork W1979542762 @default.
• W2123515677 hasRelatedWork W1990741171 @default.
• W2123515677 hasRelatedWork W2047967234 @default.
• W2123515677 hasRelatedWork W2149889282 @default.
• W2123515677 hasRelatedWork W2436724034 @default.
• W2123515677 hasRelatedWork W2439875401 @default.
• W2123515677 hasRelatedWork W2522299904 @default.
• W2123515677 hasRelatedWork W2922074762 @default.
• W2123515677 hasRelatedWork W2996730734 @default.
• W2123515677 hasVolume "50" @default.
• W2123515677 isParatext "false" @default.
• W2123515677 isRetracted "false" @default.
• W2123515677 magId "2123515677" @default.
• W2123515677 workType "article" @default.